The first malaria treatment specifically designed for infants has been officially approved for use. The drug, branded Coartem (artemether-lumefantrine) Baby, was approved by Switzerland’s health authority, Swissmedic. Until now, there was no approved malaria treatment for infants weighing less than 4.5 kg. These newborns — among the most vulnerable due to their immature immune systems […]